Quince Therapeutics, Inc. — Investor Relations & Filings
Quince Therapeutics, Inc. is a late-stage biotechnology company dedicated to developing treatments for rare diseases by leveraging a patient's own biology. The company's proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform is a drug/device combination that uses an automated process to encapsulate drugs into a patient's own red blood cells. This approach is designed to improve drug delivery, enhance tolerability, and prolong the therapeutic's circulating half-life. Its lead asset, eDSP, utilizes the AIDE platform to encapsulate the corticosteroid dexamethasone sodium phosphate. eDSP is in a pivotal Phase 3 clinical trial for the treatment of Ataxia-Telangiectasia (A-T), a rare pediatric neurodegenerative disease with no currently approved therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-27 | English | |
| 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-22 | English | |
| S-8 - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-17 | English | |
| 10-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-10 | English | |
| 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-09 | English | |
| 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-03-30 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 37630267 | ARS - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-27 | English | ||
| 35399397 | 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-22 | English | ||
| 34662711 | S-8 - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-17 | English | ||
| 34028086 | 10-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-10 | English | ||
| 33910675 | 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-04-09 | English | ||
| 33088244 | 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-03-30 | English | ||
| 33002450 | 8-K - Quince Therapeutics, Inc. (0001662774) (Filer) | 2026-03-20 | English | ||
| 32896150 | 8-K - QUINCE THERAPEUTICS, INC. (0001662774) (Filer) | 2026-02-12 | English | ||
| 31191189 | 8-K Filing | 2026-02-02 | English | ||
| 31191184 | 8-K Filing | 2026-01-29 | English | ||
| 31191172 | 4 Filing | 2026-01-23 | English | ||
| 31191148 | 4 Filing | 2026-01-23 | English | ||
| 31191137 | 4 Filing | 2026-01-23 | English | ||
| 31191238 | 4 Filing | 2026-01-21 | English | ||
| 31191200 | 4 Filing | 2026-01-21 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Quince Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34273/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34273 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34273 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34273 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34273}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Quince Therapeutics, Inc. (id: 34273)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.